Access cutting-edge alzheimers disease treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access alzheimers disease specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alzheimers disease treatment provided free
The purpose of this research study is to test the study drug, referred to as remternetug, to determine its effectiveness for the study treatment of asymptomatic (at risk) Alzheimer disease in individuals with AD-causing mutations. This study will also investigate the effects of remternetug on biomarkers (measures of the disease including brain scans, blood and spinal fluid tests), examine safety data to identify any potential benefits or risks, and examine how well participants can tolerate remt
Sponsor: Washington University School of Medicine
Check if you qualify for this alzheimers disease clinical trial in New Haven, CT
If you're searching for alzheimers disease treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alzheimers disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.